Bioavailability increased with longer post-dose fasting time, reaching a plateau around 1.4% at 120 min (Fig
Beyond diabetes, rising obesity levels present a significant opportunity, though the condition remains underdiagnosed and undertreated, said Ramana
Physicians For physicians, the clinical case for GLP-1s is getting easier but the coverage pathway is getting harder
Editor: Alejandro Torrado Pacheco, PLOS: Public Library of Science, UNITED STATES OF AMERICA Received: June 22, 2026
1 Remove Tirzepatide vial from refrigeration and allow to reach room temperature (1520 minutes) 2 Clean vial top with alcohol swab and allow to air dry completely 3 Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water) 4 Inject BAC water slowly down the side of the vial do not aim directly at the powder 5 Gently swirl in circular motions DO NOT shake vigorously as this degrades the peptide 6 Allow 23 minutes for full dissolution solution should be clear and colorless 7 Draw calculated dose into an insulin syringe for subcutaneous injection 8 Inject into abdomen, thigh, or upper arm